D1 Capital Partners

2Exits tracked$1.05bnDisclosed value$1.05bnMedian price0Acquihires

Startups backed by D1 Capital Partners that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.

Photo: Shixart1985 / Wikimedia Commons, CC BY 2.0

Healthtech & bio · Boston

Roche agrees to buy digital pathology company PathAI for up to $1.05 billion

Roche will pay $750 million upfront and up to $300 million in milestones for the Boston company, its partner since 2021, and plans to roll out PathAI's AISight lab software worldwide.

Price$1.05bnRaisedn/aLast stageSeries CBuyer typeCorporate

Latest in D1 Capital PartnersSeattle · Enterprise softwareSeismic to merge with sales enablement rival Highspot under Permira controlUndisclosedSeries D+12 Feb

All D1 Capital Partners exitsOpen tracker →

7 MayRoche → PathAIBoston · Series C · raised n/a$1.05bn$1bn+12 FebSeismic → HighspotSeattle · Series D+ · raised $648mUndisclosedUndisclosed